These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12560569)

  • 1. The proline-rich region of the ecotropic Moloney murine leukaemia virus envelope protein tolerates the insertion of the green fluorescent protein and allows the generation of replication-competent virus.
    Erlwein O; Buchholz CJ; Schnierle BS
    J Gen Virol; 2003 Feb; 84(Pt 2):369-373. PubMed ID: 12560569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide.
    Wu BW; Lu J; Gallaher TK; Anderson WF; Cannon PM
    Virology; 2000 Mar; 269(1):7-17. PubMed ID: 10725193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green fluorescent protein-tagged retroviral envelope protein for analysis of virus-cell interactions.
    Spitzer D; Dittmar KE; Rohde M; Hauser H; Wirth D
    J Virol; 2003 May; 77(10):6070-5. PubMed ID: 12719600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-mediated Moloney murine leukemia virus entry can occur independently of the clathrin-coated-pit-mediated endocytic pathway.
    Lee S; Zhao Y; Anderson WF
    J Virol; 1999 Jul; 73(7):5994-6005. PubMed ID: 10364351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A replication-competent feline leukemia virus, subgroup A (FeLV-A), tagged with green fluorescent protein reporter exhibits in vitro biological properties similar to those of the parental FeLV-A.
    Chang Z; Pan J; Logg C; Kasahara N; Roy-Burman P
    J Virol; 2001 Sep; 75(18):8837-41. PubMed ID: 11507228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a replication-competent retroviral vector for expression of the VSV-G envelope glycoprotein for cancer gene therapy.
    Jin SY; Jung YT
    Arch Virol; 2020 May; 165(5):1089-1097. PubMed ID: 32146506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine leukemia virus (MLV) replication monitored with fluorescent proteins.
    Sliva K; Erlwein O; Bittner A; Schnierle BS
    Virol J; 2004 Dec; 1():14. PubMed ID: 15610559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary.
    Logg CR; Logg A; Tai CK; Cannon PM; Kasahara N
    J Virol; 2001 Aug; 75(15):6989-98. PubMed ID: 11435579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redirecting retroviral tropism by insertion of short, nondisruptive peptide ligands into envelope.
    Gollan TJ; Green MR
    J Virol; 2002 Apr; 76(7):3558-63. PubMed ID: 11884580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric ecotropic MLV envelope proteins that carry EGF receptor-specific ligands and the Pseudomonas exotoxin A translocation domain to target gene transfer to human cancer cells.
    Erlwein O; Wels W; Schnierle BS
    Virology; 2002 Oct; 302(2):333-41. PubMed ID: 12441077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chimeric human T-cell lymphotropic virus type 1 with the envelope glycoprotein of Moloney murine leukemia virus is infectious for murine cells.
    Delebecque F; Pramberger K; Prévost MC; Brahic M; Tangy F
    J Virol; 2002 Aug; 76(15):7883-9. PubMed ID: 12097602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the R peptide cleavage site of Moloney murine leukaemia virus envelope protein.
    Kubo Y; Amanuma H
    J Gen Virol; 2003 Aug; 84(Pt 8):2253-2257. PubMed ID: 12867658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated targeting of replication-competent retroviral vectors.
    Tai CK; Logg CR; Park JM; Anderson WF; Press MF; Kasahara N
    Hum Gene Ther; 2003 May; 14(8):789-802. PubMed ID: 12804141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses.
    O'Reilly L; Roth MJ
    J Virol; 2000 Jan; 74(2):899-913. PubMed ID: 10623753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of novel syncytium-inducing and host range variants of ecotropic moloney murine leukemia virus in Mus spicilegus.
    Jung YT; Kozak CA
    J Virol; 2003 May; 77(9):5065-72. PubMed ID: 12692209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line.
    Garrett E; Miller AR; Goldman JM; Apperley JF; Melo JV
    Virology; 2000 Jan; 266(1):170-9. PubMed ID: 10612671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The block to membrane fusion differs with the site of ligand insertion in modified retroviral envelope proteins.
    Ryu BY; Zavorotinskaya T; Trentin B; Albritton LM
    J Gen Virol; 2008 Apr; 89(Pt 4):1049-1058. PubMed ID: 18343849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding.
    Valsesia-Wittmann S; Morling FJ; Hatziioannou T; Russell SJ; Cosset FL
    EMBO J; 1997 Mar; 16(6):1214-23. PubMed ID: 9135138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional interaction between the N- and C-terminal domains of murine leukemia virus surface envelope protein.
    Lu CW; Roth MJ
    Virology; 2003 May; 310(1):130-40. PubMed ID: 12788637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two point mutations produce infectious retrovirus bearing a green fluorescent protein-SU fusion protein.
    Kizhatil K; Gromley A; Albritton LM
    J Virol; 2001 Dec; 75(23):11881-5. PubMed ID: 11689670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.